Does LISINOPRIL Cause Atrophy? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Atrophy have been filed in association with LISINOPRIL (Lisinopril). This represents 0.0% of all adverse event reports for LISINOPRIL.
13
Reports of Atrophy with LISINOPRIL
0.0%
of all LISINOPRIL reports
1
Deaths
10
Hospitalizations
How Dangerous Is Atrophy From LISINOPRIL?
Of the 13 reports, 1 (7.7%) resulted in death, 10 (76.9%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Atrophy?
ADALIMUMAB (76)
ETANERCEPT (43)
METHOTREXATE (37)
TRIAMCINOLONE ACETONIDE (36)
METHYLPREDNISOLONE (34)
INTERFERON BETA-1A (33)
ALENDRONATE (32)
SECUKINUMAB (30)
RITUXIMAB (29)
FINGOLIMOD (28)
Which LISINOPRIL Alternatives Have Lower Atrophy Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE